New potential biotherapy for Alzheimer’s disease
Researchers have discovered that a modified version of an important immune cell protein could be used to treat Alzheimer’s disease. The study reveals that soluble versions of a protein called TLR5 can reduce the buildup of amyloid plaques in the brains of Alzheimer’s disease model mice and prevent the toxic peptide that forms these plaques from killing neurons.
Original source: https://www.sciencedaily.com/releases/2018/08/180829115611.htm
